BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10073690)

  • 21. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.
    Farci P; Shimoda A; Wong D; Cabezon T; De Gioannis D; Strazzera A; Shimizu Y; Shapiro M; Alter HJ; Purcell RH
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15394-9. PubMed ID: 8986822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
    Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
    J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
    Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
    Zhou YH; Sugitani M; Esumi M
    Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients.
    Hino K; Korenaga M; Orito E; Katoh Y; Yamaguchi Y; Ren F; Kitase A; Satoh Y; Fujiwara D; Okita K
    J Viral Hepat; 2002 May; 9(3):194-201. PubMed ID: 12010507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination.
    Gupte GM; Arankalle VA
    Virol J; 2012 Mar; 9():74. PubMed ID: 22452828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversification of hypervariable region 1 of hepatitis C virus after liver transplantation.
    Fan X; Di Bisceglie AM
    J Med Virol; 2003 Jun; 70(2):212-8. PubMed ID: 12696107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
    Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
    Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.
    Frasca L; Scottà C; Del Porto P; Nicosia A; Pasquazzi C; Versace I; Masci AM; Racioppi L; Piccolella E
    Hepatology; 2003 Sep; 38(3):653-63. PubMed ID: 12939592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers.
    Gismondi MI; Becker PD; Díaz Carrasco JM; Guzmán CA; Campos RH; Preciado MV
    J Viral Hepat; 2009 May; 16(5):332-9. PubMed ID: 19228286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
    Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
    Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70.
    Kato N; Nakazawa T; Ootsuyama Y; Sugiyama K; Ohkoshi S; Shimotohno K
    Jpn J Cancer Res; 1994 Oct; 85(10):987-91. PubMed ID: 7525524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.
    Zibert A; Meisel H; Kraas W; Schulz A; Jung G; Roggendorf M
    Hepatology; 1997 May; 25(5):1245-9. PubMed ID: 9141445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis.
    Fan X; Di Bisceglie AM
    Am J Gastroenterol; 2002 Jun; 97(6):1489-95. PubMed ID: 12094871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
    Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
    J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
    Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.